3 research outputs found
New frontiers in the neuroscience of the sense of agency
The sense that I am the author of my own actions, including the ability to distinguish my own from other people’s actions, is a fundamental building block of our sense of self, on the one hand, and successful social interactions, on the other. Using cognitive neuroscience techniques, researchers have attempted to elucidate the functional basis of this intriguing phenomenon, also trying to explain pathological abnormalities of action awareness in certain psychiatric and neurological disturbances. Recent conceptual, technological and methodological advances suggest several interesting and necessary new leads for future research on the neuroscience of agency. Here I will describe new frontiers for the field such as the need for novel and multifactorial paradigms, anatomically plausible network models for the sense of agency, investigations of the temporal dynamics during agentic processing and ecologically valid virtual reality applications
The feeling of agency: Empirical indicators for a pre-reflective level of action awareness
The sense of agency has been defined as the sense that I am the author of my own actions. This sense, however, is usually not reflected upon but instead pre-reflectively experienced. Experimental approaches usually measure the sense of agency by judgments or verbal reports, despite evidence that the sense of agency is not sufficiently assessed on such a reflective level. Here we sought to identify non-verbal measures of the sense of agency, particularly testing the relevance of physiological activity such as skin conductance and heart rate. Manipulating the visual feedback to an executed movement, we investigated how well physiological activity and other movement parameters differed between real and false feedback (i.e., between actual agency and non-agency), and how they related to accuracy of agency judgments. Skin conductance and heart rate did not differ between agency and non-agency situations; neither did they inform agency judgments. In contrast, movement onsets—particularly, discrepancies between feedback and movement onsets—were related to agency judgments. Overall, our results indicate weak visceral-somatic associations with the sense of agency. Thus, physiological activity did not prove to be an empirical indicator for the feeling of agency
Role of environmental confounding in the association between FKBP5 and first-episode psychosis
Background: Failure to account for the etiological diversity that typically occurs in psychiatric cohorts may increase the potential for confounding, as a proportion of genetic variance will be specific to exposures that have variable distribution in cases. This study investigated whether minimizing the potential for such confounding strengthened the evidence for a genetic candidate currently unsupported at the genome-wide level.Methods: 291 first-episode psychosis cases from South London UK, and 218 unaffected controls were evaluated for a functional polymorphism at the rs1360780 locus in FKBP5. The relationship between FKBP5 and psychosis was modelled using logistic regression. Cannabis use (Cannabis Experiences Questionnaire) and parental separation (Childhood Experience of Care and Abuse Questionnaire) were modelled as confounders in the analysis.Results: Association at rs1360780 was not detected until the effects of the two environmental factors had been adjusted for in the model (OR=2.81, 95% CI 1.23-6.43, p=0.02). A statistical interaction between rs1360780 and parental separation was confirmed by stratified tests (OR=2.8, p=0.02 vs. OR=0.89, p=0.80). The genetic main effect was directionally-consistent with findings in other (stress-related) clinical phenotypes. Moreover, the variation in effect magnitude was explained by the level of power associated with different cannabis constructs used in the model (r=0.95).Conclusions: Our results suggest that the extent to which genetic variants in FKBP5 can influence susceptibility to psychosis may depend on the other etiological factors involved. This finding requires further validation in other large independent cohorts. Potentially this work could have translational implications, as the ability to discriminate between genetic etiologies, based on a case-by-case understanding of exposure history would confer an important clinical advantage that would benefit the delivery of personalizable treatment strategie
